Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Response After The First Chemotherapy Cycle In Newly Diagnosed Breast Cancer As A Guide For Neoadjuvant Therapy

NCT01038258 is registered in ClinicalTrials.gov with Auxilio Mutuo Cancer Center as lead sponsor.

NCT NCT01038258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01038258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Response After The First Chemotherapy Cycle In Newly Diagnosed Breast Cancer As A Guide For Neoadjuvant Therapy
Lead sponsor
Auxilio Mutuo Cancer Center
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2007
Completion date
April 30, 2013
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory breast carcinoma, invasive ductal carcinoma, lobular breast carcinoma